Advertisement

Topics

Placebo-Controlled Study to Investigate ANB020 Activity in Adult Patients With Peanut Allergy

2016-10-02 23:07:51 | BioPortfolio

Published on BioPortfolio: 2016-10-02T23:07:51-0400

Clinical Trials [293 Associated Clinical Trials listed on BioPortfolio]

Mucosal Immunotherapy for Peanut Allergy in Young Children

Peanut allergy is known to cause severe anaphylactic reactions.The goal of this proposal is to produce a new treatment that would benefit young subjects who have recently been diagnosed wi...

Early Life Origins of the Food Allergy Epidemic

The purpose of this study is to determine if avoidance of peanut by children with positive allergy testing to peanut in the first 5 years of life increases the likelihood of developing a p...

Early Peanut Introduction: Translation to Clinical Practice

The recent finding that early introduction of peanut can prevent ~70-90% of peanut allergy is a major step towards prevention of food allergy. However, because that finding was from a clin...

Oral Immunotherapy (OIT) for Peanut Allergy

Peanut allergy is known to cause severe anaphylactic reactions.The goal of this proposal is to produce a new treatment that would benefit subjects who have peanut allergy by lowering the r...

Evaluating the Safety and Efficacy of Fecal Microbiota Transplant in Peanut Allergic Patients

This is a Phase I trial to evaluate the safety and efficacy of fecal microbiota transplantation (FMT) in the treatment of peanut allergy. In this research the investigators would like to l...

PubMed Articles [2026 Associated PubMed Articles listed on BioPortfolio]

Association of stat6 gene variants with food allergy diagnosed by double-blind placebo-controlled food challenges.

This study describes the role of two STAT6 gene variants in food allergy using data of patients and their parents who underwent double-blind placebo-controlled food challenges (DBPCFCs). After quality...

Identification and analysis of peanut-specific T effector and T regulatory cells in children allergic and tolerant to peanut.

Peanut allergy is potentially life-threatening and generally persists lifelong. Recent data suggests the skin may be an important route of initial sensitization to peanut, while early oral exposure to...

Peanut Gastro-Intestinal Delivery Oral Immunotherapy in Adolescents: results of the build-up phase of a randomized, double-blind, placebo-controlled trial (PITA study).

Oral immunotherapy to peanut is effective in desensitizing patients but has significant side effects including anaphylaxis and gastro-intestinal symptoms. In most protocols peanut is administered in a...

The Health and Economic Outcomes of Peanut Allergy Management Practices.

Peanut allergy is managed with strict avoidance, epinephrine carriage, and promptly treating reactions.

Peanut lipids display potential adjuvanticity by triggering a pro-inflammatory response in human keratinocytes.

Currently, the earliest cellular and molecular signals driving allergic sensitization to peanuts are not fully understood, even though peanut allergens have been studied extensively. Meanwhile, lipids...

Medical and Biotech [MESH] Definitions

Oil derived from PEANUTS.

Misunderstanding among individuals, frequently research subjects, of scientific methods such as randomization and placebo controls.

Allergic reaction to peanuts that is triggered by the immune system.

An effect usually, but not necessarily, beneficial that is attributable to an expectation that the regimen will have an effect, i.e., the effect is due to the power of suggestion.

Allergic reaction to tree nuts and peanuts, including other LEGUMES, that is triggered by the immune system. It includes co-sensitization to other food (e.g., sesame seed).

More From BioPortfolio on "Placebo-Controlled Study to Investigate ANB020 Activity in Adult Patients With Peanut Allergy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial